Arkolith/Insider Trading/TSHA/Form 4

Session R.A. II

10% OwnerTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Jun 26, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2023Sell(S)18K$0.70$13K9.0M
Jun 22, 2023Sell(S)11K$0.70$7K9.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-016491) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML